{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_names_name in Any Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 346
(2013)
Source URL:
First approved in 2010
Source:
NDA020941
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2010)
Source URL:
First approved in 2010
Source:
21 CFR 333D
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M016
(2008)
Source URL:
First approved in 2008
Source:
M016
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT03177538: Phase 4 Interventional Completed Infertility, Female
(2017)
Source URL:
First approved in 2005
Source:
PLUSET by Minitube of America, Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm071835.htm laxative:stimulant laxative sennosides a and b
Source URL:
First approved in 1998
Source:
21 CFR 334
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2010)
Source URL:
First approved in 1995
Source:
NDA022370
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2024)
Source:
BLA761248
(2024)
Source URL:
First approved in 2024
Source:
BLA761248
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2023)
Source:
BLA761184
(2023)
Source URL:
First approved in 2023
Source:
BLA761184
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2023)
Source:
BLA761269
(2023)
Source URL:
First approved in 2023
Source:
BLA761269
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2022)
Source:
BLA761228
(2022)
Source URL:
First approved in 2022
Source:
BLA761228
Source URL:
Class:
PROTEIN
